Skip to main content
biote Corp. (BTMD)
NASDAQ: BTMD · Real-Time Price · USD
6.10
+0.34 (5.90%)
Dec 20, 2024, 4:00 PM EST - Market closed

biote Revenue

biote had revenue of $51.38M in the quarter ending September 30, 2024, with 12.79% growth. This brings the company's revenue in the last twelve months to $193.06M, up 4.84% year-over-year. In the year 2023, biote had annual revenue of $185.36M with 12.37% growth.

Revenue (ttm)
$193.06M
Revenue Growth
+4.84%
P/S Ratio
1.06
Revenue / Employee
$995,155
Employees
194
Market Cap
221.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023185.36M20.40M12.37%
Dec 31, 2022164.96M25.56M18.34%
Dec 31, 2021139.40M22.83M19.58%
Dec 31, 2020116.57M6.59M5.99%
Dec 31, 2019109.98M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LifeMD 193.06M
ADC Therapeutics 70.72M
SOPHiA GENETICS 64.49M
Utah Medical Products 44.08M
Zentalis Pharmaceuticals 40.56M
Mersana Therapeutics 34.84M
Precigen 3.96M
Inhibikase Therapeutics 1.00
Revenue Rankings

BTMD News

More News